Comparison of CD-19+/HERV-W ENV+ B cell percentage increased with series of patients from Wuhan to Delta and Omicron variants (Figure 3B) and with decreasing severity of COVID-19, suggesting that HERV-W ENV+ B cells may be depleted with increasing disease severity. This evidence concerns the gene CD19 and COVID-19.